A rating of 87 puts Oncternal Therapeutics Inc (ONCT) near the top of the Biotechnology industry according to InvestorsObserver. Oncternal Therapeutics Inc's score of 87 means it scores higher than 87% of stocks in the industry. Oncternal Therapeutics Inc also received an overall rating of 54, putting it above 54% of all stocks. Biotechnology is ranked 104 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 54 means the stock is more attractive than 54 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Oncternal Therapeutics Inc Stock Today?
Oncternal Therapeutics Inc (ONCT) stock has fallen -12.44% while the S&P 500 has risen 0.1% as of 2:59 PM on Thursday, May 6. ONCT is lower by -$0.74 from the previous closing price of $5.99 on volume of 2,062,793 shares. Over the past year the S&P 500 has risen 46.46% while ONCT has risen 97.37%. ONCT lost -$0.85 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Oncternal Therapeutics Inc (ONCT) Stock.
